A detailed history of Concourse Financial Group Securities, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 100 shares of PACB stock, worth $193. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$193
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$5.97 - $10.36 $119 - $207
-20 Reduced 16.67%
100 $0
Q3 2023

Oct 25, 2023

SELL
$8.23 - $13.93 $913 - $1,546
-111 Reduced 48.05%
120 $1,000
Q1 2023

May 15, 2023

SELL
$7.94 - $12.02 $6,693 - $10,132
-843 Reduced 78.49%
231 $2,000
Q1 2022

May 09, 2022

BUY
$8.43 - $20.9 $2,233 - $5,538
265 Added 32.76%
1,074 $10,000
Q4 2021

Feb 07, 2022

SELL
$19.26 - $30.08 $23,805 - $37,178
-1,236 Reduced 60.44%
809 $17,000
Q3 2021

Nov 09, 2021

BUY
$24.86 - $35.02 $1,168 - $1,645
47 Added 2.35%
2,045 $52,000
Q2 2021

Aug 13, 2021

BUY
$22.3 - $36.02 $2,230 - $3,602
100 Added 5.27%
1,998 $69,000
Q1 2021

May 13, 2021

BUY
$26.38 - $51.15 $32,922 - $63,835
1,248 Added 192.0%
1,898 $63,000
Q4 2020

Feb 02, 2021

BUY
$10.5 - $28.5 $6,825 - $18,525
650 New
650 $17,000
Q3 2020

Nov 13, 2020

BUY
$3.61 - $9.87 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$2.65 - $4.03 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020

BUY
$2.36 - $5.26 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020

BUY
$4.6 - $5.57 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$4.99 - $6.16 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019

BUY
$5.92 - $7.41 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

BUY
$6.8 - $7.4 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018

BUY
$3.52 - $5.55 $0 - $0
0 New
0 $0

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $434M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.